293 related articles for article (PubMed ID: 31424553)
1. Efficacy of a ciprofloxacin/amikacin combination against planktonic and biofilm cultures of susceptible and low-level resistant Pseudomonas aeruginosa.
Soares A; Alexandre K; Lamoureux F; Lemée L; Caron F; Pestel-Caron M; Etienne M
J Antimicrob Chemother; 2019 Nov; 74(11):3252-3259. PubMed ID: 31424553
[TBL] [Abstract][Full Text] [Related]
2. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
[TBL] [Abstract][Full Text] [Related]
3. Real-Time Monitoring of
Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection.
Wang Y; Li C; Wang J; Bai N; Zhang H; Chi Y; Cai Y
Microbiol Spectr; 2022 Oct; 10(5):e0146822. PubMed ID: 36102678
[TBL] [Abstract][Full Text] [Related]
5. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
[TBL] [Abstract][Full Text] [Related]
7. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.
De Kievit TR; Parkins MD; Gillis RJ; Srikumar R; Ceri H; Poole K; Iglewski BH; Storey DG
Antimicrob Agents Chemother; 2001 Jun; 45(6):1761-70. PubMed ID: 11353623
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
Lister PD; Wolter DJ; Wickman PA; Reisbig MD
J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
[TBL] [Abstract][Full Text] [Related]
9. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M
Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017
[TBL] [Abstract][Full Text] [Related]
10. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
[TBL] [Abstract][Full Text] [Related]
11. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of ciprofloxacin against Pseudomonas aeruginosa planktonic and biofilm-derived cells.
Marques CNH; Nelson SM
Lett Appl Microbiol; 2019 Apr; 68(4):350-359. PubMed ID: 30740751
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
[TBL] [Abstract][Full Text] [Related]
15. Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.
Bilal H; Bergen PJ; Tait JR; Wallis SC; Peleg AY; Roberts JA; Oliver A; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366710
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
17. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
Yasmin F; Akhtar N; Hameed A
Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
[TBL] [Abstract][Full Text] [Related]
18. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
Dupont P; Hocquet D; Jeannot K; Chavanet P; Plésiat P
J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
[TBL] [Abstract][Full Text] [Related]
19.
Asempa TE; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262769
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
